Support our Foundation of Myology project
Avidity AOC 1001-CS3
A phase 3, randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of intravenous AOC 1001 in the treatment of myotonic dystrophy type 1.
Support our Foundation of Myology project
A phase 3, randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of intravenous AOC 1001 in the treatment of myotonic dystrophy type 1.